At the time of writing, Insmed Inc [INSM] stock is trading at $200.67, up 1.90%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The INSM shares have gain 3.35% over the last week, with a monthly amount glided 3.86%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on December 04, 2025, when Rothschild & Co Redburn initiated its Buy rating and assigned the stock a price target of $263. On October 20, 2025, Wells Fargo initiated with an Overweight rating and assigned a price target of $171 on the stock. William Blair started tracking the stock assigning an Outperform rating. Morgan Stanley downgraded its rating to a Equal-Weight but $126 remained the price target by the analyst firm on August 13, 2025. Jefferies started tracking with a Buy rating for this stock on May 13, 2025, and assigned it a price target of $105. In a note dated February 25, 2025, RBC Capital Mkts initiated an Outperform rating and provided a target price of $100 on this stock.
For the past year, the stock price of Insmed Inc fluctuated between $60.40 and $212.75. Currently, Wall Street analysts expect the stock to reach $232.78 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $200.67 at the most recent close of the market. An investor can expect a potential return of 16.0% based on the average INSM price forecast.
Analyzing the INSM fundamentals
According to Insmed Inc [NASDAQ:INSM], the company’s sales were 447.02M for trailing twelve months, which represents an 52.36% jump. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at -2.72%, Pretax Profit Margin comes in at -2.64%, and Net Profit Margin reading is -2.65%. To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -1.84 and Total Capital is -0.63. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 194.10 points at the first support level, and at 187.53 for the second support level. However, for the 1st resistance point, the stock is sitting at 205.64, and for the 2nd resistance point, it is at 210.61.
Ratios To Look Out For
It is important to note that Insmed Inc [NASDAQ:INSM] has a current ratio of 4.63. Also, the Quick Ratio is 4.34, while the Cash Ratio stands at 0.8. Considering the valuation of this stock, the price to sales ratio is 95.74, the price to book ratio is 45.11.
Transactions by insiders
Recent insider trading involved SHAROKY MELVIN MD, Director, that happened on Dec 05 ’25 when 20000.0 shares were sold. DIRECTOR, MELVIN SHAROKY completed a deal on Dec 05 ’25 to buy 20000.0 shares. Meanwhile, Chair and CEO Lewis William sold 10699.0 shares on Dec 04 ’25.
